AU2001247244A1 - Nanocapsule encapsulation system and method - Google Patents

Nanocapsule encapsulation system and method

Info

Publication number
AU2001247244A1
AU2001247244A1 AU2001247244A AU2001247244A AU2001247244A1 AU 2001247244 A1 AU2001247244 A1 AU 2001247244A1 AU 2001247244 A AU2001247244 A AU 2001247244A AU 2001247244 A AU2001247244 A AU 2001247244A AU 2001247244 A1 AU2001247244 A1 AU 2001247244A1
Authority
AU
Australia
Prior art keywords
nanocapsule
method
encapsulation system
encapsulation
system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001247244A
Other versions
AU2001247244B2 (en
Inventor
Gretchen M. Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GeneSegues Inc
Original Assignee
Genesegues, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US18528200P priority Critical
Priority to US60/185,282 priority
Application filed by Genesegues, Inc. filed Critical Genesegues, Inc.
Priority to PCT/US2001/006455 priority patent/WO2001064164A2/en
Publication of AU2001247244A1 publication Critical patent/AU2001247244A1/en
Application granted granted Critical
Publication of AU2001247244B2 publication Critical patent/AU2001247244B2/en
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2001247244A 2000-02-28 2001-02-28 Nanocapsule encapsulation system and method Ceased AU2001247244B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US18528200P true 2000-02-28 2000-02-28
US60/185,282 2000-02-28
PCT/US2001/006455 WO2001064164A2 (en) 2000-02-28 2001-02-28 Nanocapsule encapsulation system and method

Publications (2)

Publication Number Publication Date
AU2001247244A1 true AU2001247244A1 (en) 2001-11-22
AU2001247244B2 AU2001247244B2 (en) 2005-06-02

Family

ID=22680346

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4724401A Pending AU4724401A (en) 2000-02-28 2001-02-28 Nanocapsule encapsulation system and method
AU2001247244A Ceased AU2001247244B2 (en) 2000-02-28 2001-02-28 Nanocapsule encapsulation system and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU4724401A Pending AU4724401A (en) 2000-02-28 2001-02-28 Nanocapsule encapsulation system and method

Country Status (8)

Country Link
US (2) US6632671B2 (en)
EP (1) EP1267946A4 (en)
JP (1) JP4751556B2 (en)
CN (1) CN1406140A (en)
AU (2) AU4724401A (en)
CA (1) CA2400172C (en)
MX (1) MXPA02008361A (en)
WO (1) WO2001064164A2 (en)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433154B1 (en) 1997-06-12 2002-08-13 Bristol-Myers Squibb Company Functional receptor/kinase chimera in yeast cells
US20050281886A1 (en) * 2004-05-06 2005-12-22 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6632671B2 (en) * 2000-02-28 2003-10-14 Genesegues, Inc. Nanoparticle encapsulation system and method
US7247338B2 (en) * 2001-05-16 2007-07-24 Regents Of The University Of Minnesota Coating medical devices
JP2004500975A (en) 2000-05-16 2004-01-15 チェン，ダ　レン High throughput particle generator and particle generation method using a plurality of nozzles spraying operation
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030170309A1 (en) * 2001-06-22 2003-09-11 Babcock Walter C. Pharmaceutical compositions containing polymer and drug assemblies
US7081489B2 (en) * 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
WO2003026611A2 (en) 2001-09-26 2003-04-03 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7491810B2 (en) * 2001-11-30 2009-02-17 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
US7615676B2 (en) * 2001-11-30 2009-11-10 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US7053034B2 (en) * 2002-04-10 2006-05-30 Salvona, Llc Targeted controlled delivery compositions activated by changes in pH or salt concentration
DE10236064A1 (en) * 2002-08-07 2004-02-19 Beiersdorf Ag Foaming sunscreen preparations
US6989196B2 (en) * 2002-10-02 2006-01-24 Florida State University Research Foundation Microencapsulation of magnetic material using heat stabilization
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US7732591B2 (en) * 2003-11-25 2010-06-08 Medtronic, Inc. Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
US7829694B2 (en) 2002-11-26 2010-11-09 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7605249B2 (en) * 2002-11-26 2009-10-20 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7994149B2 (en) 2003-02-03 2011-08-09 Medtronic, Inc. Method for treatment of Huntington's disease through intracranial delivery of sirna
US8986736B2 (en) * 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
EP1663158A2 (en) * 2003-06-24 2006-06-07 Baxter International Inc. Specific delivery of drugs to the brain
DK1648467T3 (en) 2003-07-17 2018-06-25 Janssen Sciences Ireland Uc Procedure for manufacturing particles containing an antivirus agent
WO2005041865A2 (en) * 2003-10-21 2005-05-12 Igf Oncology, Llc Compounds and method for treating cancer
US9011880B2 (en) * 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
WO2005072292A2 (en) * 2004-01-24 2005-08-11 Hugh Mctavish Methods for enhancing radiation therapy
WO2005072706A2 (en) * 2004-01-29 2005-08-11 Baxter International Inc. Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
KR20050081092A (en) * 2004-02-12 2005-08-18 한국과학기술연구원 Composition and formulation of colloidal system comprising biocompatible aqueous-soluble polymer, and preparation method thereof
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US20050208090A1 (en) * 2004-03-18 2005-09-22 Medtronic, Inc. Methods and systems for treatment of neurological diseases of the central nervous system
US7842281B2 (en) * 2004-05-10 2010-11-30 The Florida State University Research Foundation Magnetic particle composition for therapeutic hyperthermia
AU2005255039A1 (en) * 2004-06-15 2005-12-29 Baxter Healthcare S.A. Ex-vivo application of solid microparticulate therapeutic agents
EP1773401B1 (en) * 2004-06-21 2013-01-02 Medtronic, Inc. Medical systems and methods for delivering compositions to cells
WO2006047214A2 (en) * 2004-10-21 2006-05-04 Igf Oncology, Llc Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
US7446157B2 (en) * 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
WO2006065724A2 (en) * 2004-12-14 2006-06-22 Regents Of The University Of Minnesota Casein kinase 2 antisense therapy
KR20070110084A (en) * 2005-02-14 2007-11-15 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 Layered nanoparticles
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
EP1885854B1 (en) * 2005-05-06 2012-10-17 Medtronic, Inc. Methods and sequences to suppress primate huntington gene expression
US7902352B2 (en) * 2005-05-06 2011-03-08 Medtronic, Inc. Isolated nucleic acid duplex for reducing huntington gene expression
CA2611506A1 (en) * 2005-05-23 2006-11-23 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
US9133517B2 (en) * 2005-06-28 2015-09-15 Medtronics, Inc. Methods and sequences to preferentially suppress expression of mutated huntingtin
DK1943016T3 (en) * 2005-10-14 2012-10-01 Vive Crop Prot Inc Composite nanoparticles, nanoparticles and processes for their preparation
CN1962155A (en) * 2005-11-10 2007-05-16 鸿富锦精密工业（深圳）有限公司 CO2 laser welding apparatus
US7741396B2 (en) * 2005-11-23 2010-06-22 General Electric Company Composites having tunable dielectric constants, methods of manufacture thereof, and articles comprising the same
US20090004114A1 (en) * 2005-12-08 2009-01-01 Koninklijke Philips Electronics N. V. System and Method for Monitoring in Vivo Drug Release Using Overhauser-Enhanced Nmr
US9108217B2 (en) 2006-01-31 2015-08-18 Nanocopoeia, Inc. Nanoparticle coating of surfaces
CA2641117C (en) 2006-01-31 2018-01-02 Nanocopoeia, Inc. Nanoparticle coating of surfaces
CA2637883C (en) 2006-01-31 2015-07-07 Regents Of The University Of Minnesota Electrospray coating of objects
WO2007127799A2 (en) * 2006-04-25 2007-11-08 Research Foundation Of The City University Of New York Polymer submicron particle preparation by surfactant- mediated precipitation
US9273356B2 (en) 2006-05-24 2016-03-01 Medtronic, Inc. Methods and kits for linking polymorphic sequences to expanded repeat mutations
US20080280843A1 (en) * 2006-05-24 2008-11-13 Van Bilsen Paul Methods and kits for linking polymorphic sequences to expanded repeat mutations
WO2007149868A2 (en) * 2006-06-20 2007-12-27 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
EP2051696A2 (en) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US7819842B2 (en) * 2006-11-21 2010-10-26 Medtronic, Inc. Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
US7988668B2 (en) * 2006-11-21 2011-08-02 Medtronic, Inc. Microsyringe for pre-packaged delivery of pharmaceuticals
US9040816B2 (en) 2006-12-08 2015-05-26 Nanocopoeia, Inc. Methods and apparatus for forming photovoltaic cells using electrospray
US20080171906A1 (en) * 2007-01-16 2008-07-17 Everaerts Frank J L Tissue performance via hydrolysis and cross-linking
EP1955695A1 (en) * 2007-02-06 2008-08-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanocapsules of lipophilic complexes of nucleic acids
US20080193766A1 (en) * 2007-02-13 2008-08-14 Northern Nanotechnologies Control of Transport to and from Nanoparticle Surfaces
JP2010526062A (en) * 2007-04-30 2010-07-29 エージェンシー フォー サイエンス， テクノロジー アンド リサーチ Methods for delivering proteins to cells
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008157514A2 (en) * 2007-06-14 2008-12-24 Genesegues, Inc. Metal ion-treated biocompatible polymers useful for nanoparticles
US20090042825A1 (en) * 2007-08-06 2009-02-12 Majed Matar Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
US9144546B2 (en) 2007-08-06 2015-09-29 Clsn Laboratories, Inc. Nucleic acid-lipopolymer compositions
US7973019B1 (en) 2007-10-03 2011-07-05 Alcon Research, Ltd. Transferrin/transferrin receptor-mediated siRNA delivery
WO2009065022A2 (en) 2007-11-15 2009-05-22 Alcon Research, Ltd. Low density lipoprotein receptor-mediated sirna delivery
WO2009073586A1 (en) * 2007-11-30 2009-06-11 Chemi Nutra, Llc. Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009085082A1 (en) * 2007-12-28 2009-07-09 Dow Global Technologies Inc. Small scale functional materials
EP2225604A1 (en) * 2007-12-28 2010-09-08 Dow Global Technologies Inc. Phase compensation film comprising polymer nanoparticles imbibed with liquid crystal material
US8871276B2 (en) 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
US20110045092A1 (en) * 2008-02-11 2011-02-24 Livney Yoav D Casein particles encapsulating therapeutically active agents and uses thereof
US8865222B2 (en) * 2008-02-11 2014-10-21 Technion Research And Development Foundation Ltd. Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof
WO2009101613A1 (en) * 2008-02-11 2009-08-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
MX2010008902A (en) * 2008-02-18 2011-03-02 Csir Nanoparticle carriers for drug administration and process for producing same.
WO2009111638A1 (en) 2008-03-05 2009-09-11 Baxter International Inc. Compositions and methods for drug delivery
IE20080211A1 (en) * 2008-03-20 2009-11-25 Nat Univ Ireland Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules
US20090269405A1 (en) * 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
WO2010006200A2 (en) * 2008-07-09 2010-01-14 Board Of Regents, The University Of Texas System Triggered release of drugs from polymer particles
WO2010102065A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
US20100290983A1 (en) * 2009-05-15 2010-11-18 Baxter International Inc. Compositions and Methods for Drug Delivery
US20110020388A1 (en) 2009-05-27 2011-01-27 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
WO2011017382A2 (en) * 2009-08-03 2011-02-10 The Regents Of The University Of California Nanofibers and morphology shifting micelles
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
MX343908B (en) 2009-08-26 2016-11-28 Selecta Biosciences Inc * Compositions that induce t cell help.
US9650244B2 (en) 2010-08-25 2017-05-16 Genesegues, Inc. Topical vaccination via DNA microparticles
US20120076735A1 (en) * 2010-03-24 2012-03-29 Genesegues, Inc. Nanoparticles for Extravascular Administration
PL2575876T3 (en) 2010-05-26 2018-07-31 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
US8709487B1 (en) 2011-04-25 2014-04-29 The United States Of America As Represented By The Secretary Of The Army Nanoparticle entrapment of materials
CN107261151A (en) 2011-04-29 2017-10-20 西莱克塔生物科技公司 Tolerogenesis for reducing antibody response synthesizes nano-carrier
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
WO2012161677A1 (en) 2011-05-20 2012-11-29 Alcon Research, Ltd. TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
EP2736537A4 (en) 2011-07-29 2015-04-15 Selecta Biosciences Inc Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
JP2014531476A (en) * 2011-08-26 2014-11-27 アローヘッド リサーチ コーポレイション Poly (vinyl ester) polymers for in vivo nucleic acid delivery
US9474715B2 (en) * 2011-11-30 2016-10-25 Andreas Voigt Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
CN103550155A (en) * 2013-11-08 2014-02-05 江南大学 Method of restraining production of lysophosphatide in lecithin/non-ionic surfactant mixed micelles
CA2936675A1 (en) 2014-01-12 2015-07-16 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
WO2015200728A1 (en) 2014-06-25 2015-12-30 Selecta Biosciences, Inc. Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
JP2017533256A (en) 2014-09-03 2017-11-09 ジーンセグエス，インコーポレイテッド Therapeutic nanoparticles and related compositions, methods, and systems
WO2016037163A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating gene therapy anti-viral transfer vector immune responses
WO2016073799A1 (en) 2014-11-05 2016-05-12 Selecta Biosciences, Inc. Methods and compositions related to synthetic nanocarriers with rapamycin in a stable, super-saturated state
KR101663775B1 (en) * 2014-11-13 2016-10-07 주식회사 엘지생활건강 Composition for stabilizing polyphenolic effective ingredient
JP2019507797A (en) 2016-03-11 2019-03-22 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． Formulation and dose of pegylated uricase
EP3518956A1 (en) 2016-09-27 2019-08-07 Selecta Biosciences, Inc. Recombinant immunotoxins for use in the treatment of cancer
EP3565572A1 (en) 2017-01-07 2019-11-13 Selecta Biosciences, Inc. Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
WO2018169811A1 (en) 2017-03-11 2018-09-20 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US20190142974A1 (en) 2017-10-13 2019-05-16 Selecta Biosciences, Inc. Methods and compositions for attenuating anti-viral transfer vector igm responses

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DK143689C (en) * 1975-03-20 1982-03-15 J Kreuter A process for preparing an adsorbed vaccine
US4177177A (en) 1976-03-26 1979-12-04 El Aasser Mohamed S Polymer emulsification process
FR2504408B1 (en) 1981-04-24 1986-02-14 Couvreur Patrick Method for preparation of submicroscopic particles, particles obtained and pharmaceutical compositions containing them
JP2765700B2 (en) 1986-08-11 1998-06-18 イノベータ・バイオメド・リミテツド Pharmaceutical formulations containing microcapsules
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
FR2634397B2 (en) 1986-12-31 1991-04-19 Centre Nat Rech Scient systems process for preparing dispersible colloidal a protein in the form of nanoparticles
AT84806T (en) 1987-04-16 1993-02-15 Christian Bindschaedler A process for producing a water insoluble polymer powder that can be redispersed in a liquid phase and methods for producing a dispersion of the polymer powder.
US4937119A (en) * 1988-12-15 1990-06-26 Hoechst Celanese Corp. Textured organic optical data storage media and methods of preparation
PH30995A (en) 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
IL98744D0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
US5487390A (en) * 1990-10-05 1996-01-30 Massachusetts Institute Of Technology Gas-filled polymeric microbubbles for ultrasound imaging
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9116610D0 (en) 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
US6113946A (en) 1992-04-03 2000-09-05 The Regents Of The University Of California Self-assembling polynucleotide delivery system comprising dendrimer polycations
US6197346B1 (en) 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
DE4223169C1 (en) 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh A process for the microencapsulation of water-soluble active ingredients
US5736156A (en) * 1995-03-22 1998-04-07 The Ohio State University Liposomal anf micellular stabilization of camptothecin drugs
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
CA2294981C (en) 1997-06-27 2012-04-03 Vivorx Pharmaceuticals, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
AU673057B2 (en) 1993-02-22 1996-10-24 Abraxis Bioscience, Llc Methods for (in vivo) delivery of biologics and compositionsuseful therefor
AT258685T (en) 1993-03-09 2004-02-15 Baxter Int Macromolecular microparticles and methods for their production
FR2704754B1 (en) * 1993-05-07 1995-06-30 Oreal Use of a glutathione alkyl ester in a cosmetic or dermatological composition for topical treatment of skin aging.
WO1995003789A1 (en) 1993-07-28 1995-02-09 The Johns Hopkins University School Of Medicine Controlled release of pharmaceutically active substances from coacervate microcapsules
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
CA2136373A1 (en) * 1993-11-29 1995-05-30 Steven W. Medina Ethoxylated acetylenic glycols having low dynamic surface tension
DE4341114A1 (en) * 1993-12-02 1995-06-08 Ifac Gmbh Emulsions comprising non-aqueous phase dispersed in oil phase
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
FR2721510B1 (en) 1994-06-22 1996-07-26 Rhone Poulenc Rorer Sa Nanoparticles filterable under sterile conditions.
US5629021A (en) 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US6165988A (en) 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP0752245B1 (en) 1995-07-05 2002-05-22 European Community Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery
US6143211A (en) 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
AU714584B2 (en) 1995-07-21 2000-01-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles
US6255457B1 (en) * 1995-09-08 2001-07-03 Beth Israel Deaconess Medical Center Tissue-specific monoclonal antibodies
KR0180334B1 (en) * 1995-09-21 1999-03-20 김윤 Drug messenger using el-2l-2 micelle and method for sealing drug to it
US5648097A (en) 1995-10-04 1997-07-15 Biotek, Inc. Calcium mineral-based microparticles and method for the production thereof
FR2742357B1 (en) 1995-12-19 1998-01-09 Rhone Poulenc Rorer Sa Nanoparticles Stabilized and filtered under sterile conditions
DE19605279A1 (en) 1996-02-13 1997-08-14 Hoechst Ag Target cell-specific vectors for the introduction of genes into cells, to medicaments containing such vectors and the use thereof
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6143037A (en) 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
CA2258851A1 (en) * 1996-06-27 1997-12-31 Karen L. Wooley Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
FR2751222B1 (en) * 1996-07-16 1998-10-09 Capsulis Compositions containing at least one nucleic acid and their applications in the biomedical field, in particular in gene therapy
US6030956A (en) * 1996-10-24 2000-02-29 Boulikas; Teni Combination gene therapy for human cancers
EP0951546A2 (en) * 1996-12-20 1999-10-27 Board Of Regents The University Of Texas System Compositions and methods of use for osteoclast inhibitory factors
US5874111A (en) 1997-01-07 1999-02-23 Maitra; Amarnath Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
EP0860167A1 (en) 1997-01-30 1998-08-26 Robert Gurny RNA-and DNA- based active agents in nanoparticles
KR100980063B1 (en) * 1997-02-07 2010-09-03 디 이스테이트 오브 레오 지. 니콜라즈, 디시스트 Method for determining a phase alignment of a three-phase line synchronous generator
EP0973928B1 (en) * 1997-03-11 2010-05-05 Regents Of The University Of Minnesota Dna-based transposon system for the introduction of nucleic acid into dna of a cell
KR100236771B1 (en) 1997-04-01 2000-02-01 성재갑 Hyaluronate microparticles for sustained release of drug
JP3910646B2 (en) * 1997-04-07 2007-04-25 第一製薬株式会社 "Composition for gene transfer into cells"
DE19723308A1 (en) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Microemulsions useful for topical administration of e.g. local anaesthetics
US6165440A (en) 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
MY131805A (en) * 1997-09-18 2007-09-28 Biogen Idec Inc Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
WO1999033558A1 (en) 1997-12-29 1999-07-08 Universite De Geneve Method for producing an aqueous colloidal dispersion of nanoparticles
IT1298575B1 (en) * 1998-02-06 2000-01-12 Vectorpharma Int Pharmaceutical compositions in the form of nanoparticles comprising lipid substances and antifiliche substances and related process
JP4693238B2 (en) 1998-06-19 2011-06-01 オバン・エナジー・リミテッド Method for producing submicron particles of water insoluble compounds
CN1213733C (en) * 1998-11-20 2005-08-10 斯凯伊药品加拿大公司 Method of preparing stable suspension of insoluble microparticles
CA2361569A1 (en) 1999-02-12 2000-08-17 Dale P. Devore Injectable collagen-based system for delivery of cells or therapeutic agents
US6632671B2 (en) * 2000-02-28 2003-10-14 Genesegues, Inc. Nanoparticle encapsulation system and method
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
WO2006065724A2 (en) * 2004-12-14 2006-06-22 Regents Of The University Of Minnesota Casein kinase 2 antisense therapy
US20090238883A1 (en) * 2006-04-28 2009-09-24 Kren Betsy T Liver-specific nanocapsules and methods of using

Similar Documents

Publication Publication Date Title
GB2363285B (en) Communication system and method
AU780325C (en) Information processing system and method
AU2002234211A1 (en) Position location system and method
AU4150601A (en) International banking system and method
AU2002218899A1 (en) System and method for judging boundary lines
AU2001255394A1 (en) Method and system for pricing options
AU2002216192A1 (en) Secure file transfer method and system
AU5868101A (en) Authentication system and method
AU2002357809A1 (en) System and method for identifying desirable subscribers
AU2002241229A1 (en) Method and system for intubation
AU4225100A (en) Product authentication system and method
AU2002243209A1 (en) Method and system for remote gaming
AU2635101A (en) Policy notice method and system
AU2748901A (en) Context matching system and method
MXPA02006425A (en) Sourcing system and method.
AU4912901A (en) Communication system and method
AU4920001A (en) Fax-to-email and email-to-fax communication system and method
AU2002323310A1 (en) Method and system for transferring stored value
AU6072801A (en) On demand contents providing method and system
AU2002361342A1 (en) System and method for selecting access point
AU6777800A (en) Network system and method
AU4197200A (en) System and method for dimensioning objects
AU6819901A (en) System and method for integrating multiple applications
ZA200203727B (en) Method and system for advertising.
AU2279401A (en) Intelligent transceiving method, device and system